VIORGON-22 protein-peptide bioregulator
Form of release: one vial contains 30ml (~ 600 drops).
For irrigation of the throat and nasopharynx. Sterile solution.
Peptide preparation is not a medicine.
VIORGON-22 PROTEIN-PEPTIDE BIOREGULATOR is intended for disorders of the nervous system, diabetes mellitus, and neoplasms of the gastrointestinal tract.
Indications for use:
- Prevention and treatment of viral diseases (ARI, ARI, influenza, coronavirus infection);
- Allergic diseases (urticaria, bronchial asthma);
- Musculoskeletal diseases (rheumatism, radiculitis, arthritis);
- Skin diseases (neurodermatitis, eczema, fungal infection);
- Nervous system diseases (headache, neurasthenia, hypertension, epilepsy, seizures, paralysis, multiple sclerosis);
- Endocrine disorders (menopause, dysmenorrhea, impotence, thyroid dysfunction, type 2 diabetes);
- Immunocomial disorders (frequent infections, tuberculosis);
- Radiation exposure and consequences (including X-ray dermatitis, radiation damage to the skin and mucous membranes);
- Neoplasms;
- Leukemia, lymphomas.
Composition:
Composition: 1 ml of sterile solution contains: demineralized water, 0.1±0.01 mg CaCl2, and 10-9-10-10 mg of a protein-peptide complex isolated from the fruiting bodies of the red fly agaric (Amanita muscaria).
Substance (tissue bioregulator): Fruiting bodies of the red fly agaric (Amanita muscaria).
Physiological action:
- It has antitumor, anti-inflammatory, antiviral, and antibacterial (antiseptic, bactericidal) activity;
- It has an antihistamine effect;
- It has a regulatory effect on the body's nervous system and normalizes blood pressure;
- It has properties similar to those of bifunctional alkylating agents, which form inter- and intra-strand cross-links in DNA, thereby disrupting its function and leading to tumor death. However, the bioregulator lacks cyclic and phase specificity.
Method of application:
Place 5-15 drops of the bioregulator under the tongue at least 10 minutes before or 10 minutes after meals.
or
Dissolve 10 drops of the preparation in 100 ml of water (half a glass), mix thoroughly, and take the solution several times throughout the day.
Important!
- It is recommended to take each Viorgon at least twice daily.
- Two or more Viorgons should not be mixed in the same dose.
- The time interval between doses should be 5-10 minutes.
Advantages:
- Do not cause allergic reactions;
- Do not cause overdoses (no toxic or even dyspeptic dose);
- Do not have side effects or contraindications;
- Facilitate the restoration of the normal structure and function of pathologically altered tissues and are resistant to a number of physicochemical factors;
- Compatible with any pharmacotherapy (including antibiotics, chemotherapy), radiation therapy, and physical therapy, as they are resistant to a number of physicochemical factors;
- Compatible with any naturopathic method – herbal medicine, hirudotherapy, and homeopathic remedies;
- Can be administered at any stage of the disease and inflammatory process;
- If necessary, several Viorgons can be prescribed simultaneously for the correction and prevention of several diseases;
- Viorgons are non-addictive! (This is important for long-term management of chronic diseases).
Form of release:
one vial contains 30ml (~ 600 drops).
For irrigation of the throat and nasopharynx. Sterile solution.
Peptides represent a significant class of biological molecules that play essential roles in numerous physiological processes. They are involved in regulating biological activity, supporting immune function, and maintaining the structural integrity of tissues. Owing to their distinct molecular structure and their capacity to interact with other biomolecules, peptides have substantial potential in medicine, research, and industrial applications.
The world's only protein-peptide complex MGTBio.
Shelf life: The bioregulator is valid for 3 years from the date of production, and 24 months after opening.
This is not a medicine. It is recommended to consult a doctor before using this product.

Guaranteed authenticity and quality:
100% Original from the Institute of Bioregulation Problems (Russian Federation).
The Institute of Bioregulation Problems is a private research and production company specializing in the development of protein-peptide complexes and bioregulatory agents (MGTBio).
We also conduct research and development, collaborating with various Russian Academy of Sciences institutes and medical organizations.
To date, we have published over 250 scientific papers and received over 10 patents on protein-peptide bioregulator research.
Development and production:
INSTITUTE OF BIOREGULATION PROBLEMS (Produced in Russia)



